Skip to main content

Peer Review reports

From: Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR)

Original Submission
16 Nov 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
27 Nov 2013 Author responded Author comments - Wonshik Han
10 Jun 2013 Reviewed Reviewer Report - Lev Berstein
11 Oct 2013 Reviewed Reviewer Report - Ryan Dowling
25 Oct 2013 Reviewed Reviewer Report - Marco Alessandro Pierotti
Resubmission - Version 4
27 Nov 2013 Submitted Manuscript version 4
Publishing
3 Mar 2014 Editorially accepted
10 Mar 2014 Article published 10.1186/1471-2407-14-170

You can find further information about peer review here.

Back to article page
\